Surgical Management of Mammary Gland Tumor in Cat: A Case Report

Abstract

A 12.5-year-old female cat was referred to the Teaching and Training Pet Hospital and Research Center at CVASU after showing symptoms of inappetence, decreased water intake, non-responsiveness to medication, and growth that had been growing every day for the previous month. During the clinical examination, dyspnea and caudal abdominal edema were found. The cat was found to have a malignant mammary tumor after a number of diagnostic tests. The cat was pre-medicated with a combination of xylazine hydrochloride (1 mg/kg body weight, IM) and atropine sulfate (0.04 mg/kg body weight) for surgical correction. A 50 g tumorous mass was excised during surgery. Vicryl 2-0 absorbable sutures were used in a simple, continuous manner to seal the muscles and subcutaneous tissue. The skin was sealed using a simple interrupted suture. After surgery, post-operative care was given. Through histological investigation, fibrosarcoma of the mammary gland was identified. A follow-up was advised after ten days. Following the successful treatment, the recovery process proceeded well. Doxorubicin was used as chemotherapy for six weeks. There were no metastases observed during this period. Furthermore, no odd symptoms or indications were observed during this period. Prevention through early bitch spaying and a suitable diagnostic strategy may still be major factors driving the improvement of the results, but more research into molecular approaches can be seen as new possible avenues in the tendency of the therapy of the pathology.